Dr. Deborah Armstrong Quotes
In our trial, women who received part of their chemotherapy via an IP route had a median survival time of 16 months longer than women who received only IV chemotherapy.
Tweet
Trial | Women | Received | Part | Chemotherapy |
comments powered by Disqus
This is the longest survival reported to date for advanced ovarian cancer.
- Dr. Deborah Armstrong
